Creative Medical Technology Holdings, Inc. Proceeds from Lines of Credit
Creative Medical Technology Holdings, Inc. (CELZ) reported Proceeds from Lines of Credit of $462.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2022-03-30
- Creative Medical Technology Holdings, Inc. proceeds from lines of credit for the quarter ending 2021-12-31 was -$243.41K.
- Creative Medical Technology Holdings, Inc. proceeds from lines of credit for the quarter ending 2021-09-30 was $506.50K.
- Creative Medical Technology Holdings, Inc. proceeds from lines of credit for the quarter ending 2020-09-30 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from lines of credit for fiscal 2021 was $462.00K.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$243.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $263.09K derived: sum of 2 quarters · filed 2022-03-30 | $462.00K 10-K · filed 2022-03-30 | |
| 2021-09-30 | $506.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $705.40K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $198.91K 10-Q · filed 2021-08-16 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |